Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital

Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital (SCREENING Study)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04380792

Acronym

SCREENING

Enrollment

2497

Registered

2020-05-08

Start date

2020-04-13

Completion date

2020-10-13

Last updated

2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Brief summary

The main objectives are: * To establish the prevalence of deep venous thrombosis through ultrasonography in Patients infected with COVID-19 admitted to hospital. * To identify patients with higher risk of deep venous thrombosis.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients infected with COVID-19. * Admission to hospital.

Exclusion criteria

* Patients treated with ECMO (Extracorporeal membrane oxygenation).

Design outcomes

Primary

Measure	Time frame	Description
VTE events and complications	30 days	Study endpoints are clinically recognized (and objectively confirmed) recurrences of VTE, major and minor bleeding complications, and death.

Countries

Spain

Outcome results